Impressive results for acoziborole, a new single-dose oral drug: 95% efficacy against human African #trypanosomiasis (sleeping sickness caused by T.b. gambiense). An important step towards WHO's goal of elimination by 2030 #DNDI H/T @onisillos
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00660-0/fulltext